QuiVad

Home / Spain / Laboratorios Farmaceuticos Rovi, S.A.

Laboratorios Farmaceuticos Rovi, S.A.

ES0157261019 Short position disclosed on July 24, 2026.

Evolution of the disclosed total

2.91.50.0
Sum of open short positions, as % of capital. From February 22, 2011 to July 24, 2026, peak 2.94%.

Open positions

The funds disclosing a short position that is still open.
Fund% of capitalSince
JPMorgan Asset Management (UK) Limited1.51%July 24, 2026

History of disclosures

14 disclosures on record for this share.
DateFund% of capitalEnd of publication
July 24, 2026JPMorgan Asset Management (UK) Limited1.51%still open
May 8, 2026Citadel Advisors LLC0.47%still open
May 7, 2026Citadel Advisors LLC0.51%still open
March 18, 2025Jpmorgan Asset Management (UK) Limited0.60%still open
March 13, 2025Jpmorgan Asset Management (UK) Limited0.50%still open
May 22, 2024Marshall Wace LLP0.49%still open
February 28, 2024Marshall Wace LLP0.50%still open
March 30, 2023Voleon Capital Management LP0.47%still open
March 28, 2023Voleon Capital Management LP0.51%still open
February 22, 2023Voleon Capital Management LP0.39%still open
February 21, 2023Voleon Capital Management LP0.51%still open
April 12, 2011Jpmorgan Asset Management (UK) Limited0.50%still open
March 15, 2011Jpmorgan Asset Management (UK) Limited0.60%still open
February 22, 2011Jpmorgan Asset Management (UK) Limited0.61%still open